Merantix Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Cambriumcambrium.bioNov 2023
Cambrium designs novel molecules and materials by combining AI with bioscience disciplines such as molecular biology, protein engineering, and material science.
AI & Machine LearningBiotechDeep TechNew Materials
Mitchell Duffy(CEO)inCharlie Cotton, PhD(Founder)in
Co-investorsDG Daiwa VenturesEarth Venture CapitalGradient VenturesJuniperSBI Ventures Europe GmbHTranspose Platform Management+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.